This was the question of
today about sweating in sleep...
In clinical context, nocturnal sweating can be a sensitive sign of sleep apnea. But, its not specific.
Sweating often improves with OSA treatment.
JR
Infants
Sleep. 1993 Aug;16(5):409-13.
Clinical symptoms associated with brief obstructive sleep apnea in normal infants.
Kahn A1, Groswasser J, Sottiaux M, Rebuffat E, Sunseri M, Franco P, Dramaix M, Bochner A, Belhadi B, Foerster M.
Abstract
- PMID:
- 8378681
- [PubMed - indexed for MEDLINE]
Children
Arch Dis Child. 2012 May;97(5):470-3. doi: 10.1136/adc.2010.199638. Epub 2011 Mar 22.
Night sweats in children: prevalence and associated factors.
Abstract
OBJECTIVE:
STUDY DESIGN:
RESULTS:
CONCLUSION:
- Respiratory medicine
Nocturnal sweating—a common symptom of obstructive sleep apnoea: the Icelandic sleep apnoea cohort
- Erna Sif Arnardottir1,2,
- Christer Janson3,
- Erla Bjornsdottir1,2,
- Bryndis Benediktsdottir1,2,
- Sigurdur Juliusson4,
- Samuel T Kuna5,6,
- Allan I Pack5,
- Thorarinn Gislason1,2
+Author Affiliations
- Correspondence toDr Thorarinn Gislason; thorarig@landspitali.is
- Received 26 February 2013
- Accepted 10 April 2013
- Published 14 May 2013
Abstract
Objectives To estimate the prevalence and characteristics of frequent nocturnal sweating in obstructive sleep apnoea (OSA) patients compared with the general population and evaluate the possible changes with positive airway pressure (PAP) treatment. Nocturnal sweating can be very bothersome to the patient and bed partner.
Design Case–control and longitudinal cohort study.
Setting Landspitali—The National University Hospital, Iceland.
Participants The Icelandic Sleep Apnea Cohort consisted of 822 untreated patients with OSA, referred for treatment with PAP. Of these, 700 patients were also assessed at a 2-year follow-up. The control group consisted of 703 randomly selected subjects from the general population.
Intervention PAP therapy in the OSA cohort.
Main outcome measures Subjective reporting of nocturnal sweating on a frequency scale of 1–5: (1) never or very seldom, (2) less than once a week, (3) once to twice a week, (4) 3–5 times a week and (5) every night or almost every night. Full PAP treatment was defined objectively as the use for ≥4 h/day and ≥5 days/week.
Results Frequent nocturnal sweating (≥3× a week) was reported by 30.6% of male and 33.3% of female OSA patients compared with 9.3% of men and 12.4% of women in the general population (p<0 .001="" 11.5="" 33.2="" adjustment="" after="" age="" and="" cardiovascular="" change="" compared="" decreased="" demographic="" difference="" disease="" factors.="" for="" frequent="" from="" full="" hypertension="" in="" insomnia="" nocturnal="" non-users="" of="" p="" pap="" prevalence="" related="" remained="" significant="" sleepiness="" sweating="" symptoms.="" the="" this="" to="" treatment="" was="" with="" younger="">0>
Conclusions The prevalence of frequent nocturnal sweating was threefold higher in untreated OSA patients than in the general population and decreased to general population levels with successful PAP therapy. Practitioners should consider the possibility of OSA in their patients who complain of nocturnal sweating.
Article summary
Article focus
- Previous studies have suggested a possible relationship between obstructive sleep apnoea and frequent nocturnal sweating. However until now, studies comparing the prevalence of frequent nocturnal sweating in untreated sleep apnoea patients compared with the general population as well as changes with sleep apnoea treatment have been lacking. Our study focuses on the role of nocturnal sweating in sleep apnoea.
Key messages
- Our study indicates a possible role of frequent nocturnal sweating as a marker for untreated sleep apnoea. One-third of adults with sleep apnoea experience this symptom and they are three times more likely to report it compared with adults in the general population. The symptom is responsive to treatment in the majority of sleep apnoea patients.
- Clinicians should include sleep apnoea in the differential diagnosis of patients presenting with a complaint of nocturnal sweating and further investigate that possibility.
Strengths and limitations of this study
- The strengths of this study include the detailed assessment of a large number of sleep apnea patients studied with a two year follow-up and the comparison with a general population cohort.
- Our study was an observational study, not a randomised controlled trial, which may be considered a limitation. Other limitations include the use of subjective measures of sweating and the smaller number of women with sleep apnea than men, due to lower prevalence.
No comments:
Post a Comment